Zepbound™

Zepbound™, a tirzepatide injection, stands as the unique and pioneering treatment for obesity. It distinctively targets and activates the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors, a first in its class.
Get Started Full product details
  • Blood

    Lowers A1C levels

  • Clock

    Helps you feel full faster, longer

  • Pill

    Improves the way your body responds to sugars

  • Stethoscope

    In a study of 2539 adults, 1 in 3 patients taking Zepbound at the highest dose lost up to 58 pounds (25% of their body weight)*

One subcutaneous injection weekly as directed by your Healthcare provider

Common side effects with Zepbound™ include:

  • Redness & itching at the injection site

  • Loss of appetite

  • Tiredness

  • Nausea

  • Upset stomach

  • Diarrhea, or constipation may occur
* Only available if prescribed after an online consultation with a healthcare provider.
* This page has been medically reviewed
* Actual price to customer will depend on product and subscription plan purchase.

Ana

Ana

Lost 37lbs

“Since I started using Zepbound, I've felt a positive shift in my overall well-being. It's not just a product; it's become an essential part of my lifestyle, helping me feel my best every day..”
Suzy

Suzie

Lost 34lbs

“Mounjaro totally changed the game for me! I lost the extra weight without even trying, and now I've got this crazy energy boost. It's like my secret weapon for a healthier, happier me!”
Letitia

Letitia

Lost 39lbs

“This little wonder has not only helped me manage my blood sugar levels effectively but has also given me a renewed sense of control and vitality. Grateful for the positive impact it's had on my life”
Get Started
Zepbound tilted

What are GLP-1s?

GLP-1s are ground breaking weight loss medications that work differently from older generations like phentermine.

They focus on important metabolic pathways to achieve sustainable weight loss. HMR providers prescribe various GLP-1 medications, including tirzepatide, semaglutide and liraglutide, which you might recognize as Wegovy®, Saxenda®, Ozempic®, or Mounjaro®.

Columns Zepbound

A better option for weight loss

In a 72-week study of 2,539 adults, patients lost an average of 48 lbs. (at 15mg dose) and 34 lbs. (at 5mg dose). 


1 in 3 patients using a 15mg dose lost over 58 lbs.* 

* Based on results from the phase 3 SURMOUNT-1 trial, a study of 2,539 adults with obesity, or excess weight and weight-related medical problems not including diabetes, studying people taking Zepbound as an adjunct to diet and exercise experienced substantial weight loss compared with placebo at 72 weeks. Additionally, 1 in 3 patients taking Zepbound at the highest dose lost over 58 lb. (25% of body weight), compared to 1.5% on placebo, according to data not controlled for type 1 error. The average starting weight was 231 lb.